Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0003 Transporter Info | ||||
| Gene Name | ABCB1 | ||||
| Transporter Name | P-glycoprotein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Mirabegron Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 9865528 | ||||
| Docking Score | -9.99 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C21H24N4O2S | ||||
| Molecular Weight | 396.5 | ||||
| Canonical SMILES |
C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
|
||||
| InChI |
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
|
||||
| InChIKey | PBAPPPCECJKMCM-IBGZPJMESA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.1 | Rotatable Bond Count | 9 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 6 | ||
| Xenobiotic Name | Nefazodone Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 4449 | ||||
| Docking Score | -9.947 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C25H32ClN5O2 | ||||
| Molecular Weight | 470 | ||||
| Canonical SMILES |
CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl
|
||||
| InChI |
InChI=1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3
|
||||
| InChIKey | VRBKIVRKKCLPHA-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.3 | Rotatable Bond Count | 10 | |
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 5 | ||
| Xenobiotic Name | Naringin Drug Info | ||||
| Xenobiotic Type | Investigative Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 442428 | ||||
| Docking Score | -9.944 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C27H32O14 | ||||
| Molecular Weight | 580.5 | ||||
| Canonical SMILES |
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC=C(C=C5)O)O)CO)O)O)O)O)O
|
||||
| InChI |
InChI=1S/C27H32O14/c1-10-20(32)22(34)24(36)26(37-10)41-25-23(35)21(33)18(9-28)40-27(25)38-13-6-14(30)19-15(31)8-16(39-17(19)7-13)11-2-4-12(29)5-3-11/h2-7,10,16,18,20-30,32-36H,8-9H2,1H3/t10-,16-,18+,20-,21+,22+,23-,24+,25+,26-,27+/m0/s1
|
||||
| InChIKey | DFPMSGMNTNDNHN-ZPHOTFPESA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.5 | Rotatable Bond Count | 6 | |
| Hydrogen Bond Donor Count | 8 | Hydrogen Bond Acceptor Count | 14 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.